Cabunilas, John Mark N.
HRN: 15-51-72 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2025
CEFUROXIME 750MG (VIAL)
01/31/2025
02/07/2025
IVT
750mg
Q8
Gastritis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes